Dr. Ronald Jefferson, M.D

NPI: 1730389800
Total Payments
$92,651
2024 Payments
$11,212
Companies
19
Transactions
457

Payment Breakdown by Category

Other$78,580 (84.8%)
Food & Beverage$10,115 (10.9%)
Travel$3,636 (3.9%)
Education$320.07 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $78,580 49 84.8%
Food and Beverage $10,115 377 10.9%
Travel and Lodging $3,636 23 3.9%
Education $320.07 8 0.3%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $68,016 234 $0 (2024)
Janssen Products, LP $16,934 24 $0 (2019)
Merck Sharp & Dohme LLC $3,484 48 $0 (2024)
ViiV Healthcare Company $1,686 47 $0 (2024)
Janssen Biotech, Inc. $1,039 56 $0 (2023)
AbbVie, Inc. $461.12 9 $0 (2019)
Napo Pharmaceuticals Inc $289.51 5 $0 (2024)
Theratechnologies Inc. $270.27 10 $0 (2019)
EMD Serono, Inc. $147.85 7 $0 (2021)
E.R. Squibb & Sons, L.L.C. $94.86 5 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $11,212 41 Gilead Sciences, Inc. ($10,429)
2023 $9,675 48 Gilead Sciences, Inc. ($8,879)
2022 $4,217 30 Gilead Sciences, Inc. ($3,932)
2021 $3,948 9 Gilead Sciences, Inc. ($3,887)
2020 $2,702 33 Gilead Sciences, Inc. ($2,436)
2019 $12,548 88 Gilead Sciences, Inc. ($11,334)
2018 $17,668 83 Gilead Sciences, Inc. ($8,729)
2017 $30,680 125 Gilead Sciences Inc ($18,390)

All Payment Transactions

457 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/13/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $25.93 General
12/05/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $25.38 General
Category: INFECTIOUS DISEASE
11/22/2024 Napo Pharmaceuticals Inc Mytesi (Drug) Food and Beverage Cash or cash equivalent $124.98 General
Category: Infectious Disease
11/01/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $28.29 General
10/31/2024 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,980.00 General
Category: HIV
10/30/2024 Gilead Sciences, Inc. Biktarvy (Drug) Travel and Lodging In-kind items and services $655.71 General
Category: HIV
10/30/2024 Gilead Sciences, Inc. Biktarvy (Drug) Food and Beverage In-kind items and services $121.58 General
Category: HIV
10/26/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $54.74 General
10/25/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $31.76 General
Category: INFECTIOUS DISEASE
10/22/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $33.01 General
Category: HIV
10/10/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $33.02 General
08/30/2024 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $118.26 General
Category: HIV
08/10/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $33.02 General
08/02/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $23.57 General
Category: HIV
07/23/2024 Merck Sharp & Dohme LLC GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 Food and Beverage In-kind items and services $19.72 General
Category: VACCINE
07/18/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $22.63 General
Category: INFECTIOUS DISEASE
06/27/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $24.30 General
06/21/2024 ViiV Healthcare Company DOVATO (Drug) Food and Beverage In-kind items and services $22.57 General
Category: HIV
05/30/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $26.51 General
05/16/2024 Napo Pharmaceuticals Inc Mytesi (Drug) Food and Beverage Cash or cash equivalent $32.28 General
Category: Infectious Disease
05/13/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $26.41 General
Category: INFECTIOUS DISEASE
05/06/2024 ViiV Healthcare Company CABENUVA (Biological) Food and Beverage In-kind items and services $27.72 General
Category: HIV
04/26/2024 ViiV Healthcare Company Food and Beverage In-kind items and services $123.03 General
04/25/2024 Merck Sharp & Dohme LLC PIFELTRO (Drug), DELSTRIGO Food and Beverage In-kind items and services $19.37 General
Category: INFECTIOUS DISEASE
04/20/2024 Gilead Sciences, Inc. Biktarvy (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,210.00 General
Category: HIV

About Dr. Ronald Jefferson, M.D

Dr. Ronald Jefferson, M.D is a General Practice healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1730389800.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Jefferson, M.D has received a total of $92,651 in payments from pharmaceutical and medical device companies, with $11,212 received in 2024. These payments were reported across 457 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($78,580).

Practice Information

  • Specialty General Practice
  • Location Los Angeles, CA
  • Active Since 07/18/2007
  • Last Updated 07/18/2007
  • Taxonomy Code 208D00000X
  • Entity Type Individual
  • NPI Number 1730389800

Products in Payments

  • Biktarvy (Drug) $30,004
  • PREZCOBIX (Drug) $9,140
  • Genvoya (Drug) $4,681
  • Descovy (Drug) $3,274
  • ISENTRESS (Drug) $3,128
  • Odefsey (Drug) $1,524
  • DOVATO (Drug) $635.54
  • Symtuza (Drug) $465.12
  • APRETUDE (Biological) $341.44
  • Mavyret (Drug) $336.12
  • Mytesi (Drug) $289.51
  • PIFELTRO (Drug) $191.75
  • CABENUVA (Biological) $185.00
  • TROGARZO (Drug) $178.57
  • SYMTUZA (Drug) $152.38
  • Vemlidy (Drug) $125.00
  • Viekira (Drug) $125.00
  • RUKOBIA (Drug) $123.06
  • GARDASIL (Biological) $118.29
  • SEROSTIM (Biological) $104.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

General Practice Doctors in Los Angeles